Patient Individual Therapy as Appropriate Comparator in Amnog-Dossiers in The Field of Oncology- Status Quo and Strategic Implications For Pharmaceutical Companies
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2318
https://www.valueinhealthjournal.com/article/S1098-3015(16)33684-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2199
First Page :
A752
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33684-1&doi=10.1016/j.jval.2016.09.2318